Development of Pancreatic Cancer, Disease-specific Mortality, and All-Cause Mortality in Patients with Nonresected IPMNs: A Long-term Cohort Study
Authors:
- Naoyoshi NagataNNNaoyoshi Nagata
- Akihito KawazoeAKAkihito Kawazoe
- Saori MishimaSMSaori Mishima
- Tatsuya WadaTWTatsuya Wada
- Takuro ShimboTSTakuro Shimbo
- Katsunori SekineKSKatsunori Sekine
- Kazuhiro WatanabeKWKazuhiro Watanabe
- Koh ImbeKIKoh Imbe
- Yasushi KojimaYKYasushi Kojima
- Keigo KumazawaKKKeigo Kumazawa
- Fuminori MiharaFMFuminori Mihara
- Makoto TokuharaMTMakoto Tokuhara
- 1 January 2016
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 278 (1) , 125-134
Abstract
Patients with main duct (MD) intraductal papillary mucinous neoplasms (IPMNs) have a greater risk of developing pancreatic cancer and consequent death than patients without MD-IPMNs; however, cyst size was not associated with these outcomes. Purpose To determine the cumulative incidence, disease-specific mortality, and all-cause mortality of pancreatic cancer (PC) in patients with intraductal papillary mucinous neoplasms (IPMNs) and to identify imaging findings that are associated with these outcomes. Materials and Methods This retrospective study had institutional review board approval, and the need to obtain patient consent was waived. Data from an electronic database were analyzed and supplemented by chart reviews for 285 patients with nonresected IPMNs who were periodically followed up with imaging (1273 multidetector computed tomography and 750 magnetic resonance cholangiopancreatography examinations). The Kaplan-Meier method was used to estimate the cumulative development of PC, PC mortality, and all-cause mortality (factors were compared by using the log-rank test). Results Over a median imaging follow-up period of 39 months, 12 (4.2%) of 285 patients developed PC; the cumulative 5-year PC incidence was 3.9% for branch duct (BD)-IPMNs,...Keywords
This publication has 30 references indexed in Scilit:
- Advanced-stage pancreatic cancer: therapy optionsNature Reviews Clinical Oncology, 2013
- Natural History of Branch Duct Intraductal Papillary Mucinous Neoplasms of the PancreasPancreas, 2011
- Intraductal Papillary Mucinous Neoplasms of the PancreasAnnals of Surgery, 2009
- Usefulness of Multidetector Computed Tomography for Detecting Protruding Lesions in Intraductal Papillary Mucinous Neoplasm of the Pancreas in Comparison With Single-Detector Computed Tomography and Endoscopic UltrasonographyPancreas, 2009
- Prevalence of Unsuspected Pancreatic Cysts on MDCTAmerican Journal of Roentgenology, 2008
- Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreasGut, 2008
- Survival and Prognosis of Invasive Intraductal Papillary Mucinous Neoplasms of the PancreasPancreas, 2008
- Treatment Guidelines for Branch Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas: When Can We Operate or Observe?Annals of Surgical Oncology, 2007
- Cystic Pancreatic NeoplasmsAnnals of Surgery, 2004
- Cytologic criteria for well differentiated adenocarcinoma of the pancreas in fine-needle aspiration biopsy specimensCancer, 2002